Benchmarking Oncology Navigation: What the Data Shows

Label Icon

Artem Petrov

Label Icon

Published on

March 12, 2026

Blog Thumbnail

Patient navigation has evolved from a supportive service into a measurable operational capability in oncology. A growing body of research shows that navigation programs improve time to diagnosis, accelerate treatment initiation, enhance patient experience and outcomes, reduce health care cost, and improve ROI. More recently, real-world programs and new reimbursement pathways are allowing oncology practices and hospitals to make navigation a sustainable part of clinical operations.

Navigation consistently improves the timeliness of care

The strongest evidence for oncology navigation relates to the speed of care delivery. Multiple studies show that navigation reduces delays between abnormal screening, diagnosis, and treatment initiation.

For example, the Patient Navigation Research Program, which included more than 10,000 participants with abnormal cancer screening results, found that navigation significantly accelerated diagnostic resolution and treatment initiation compared with usual care.

Systematic reviews across cancer populations report similar findings, with many studies demonstrating faster diagnosis and improved treatment initiation timelines when navigation programs are in place.

Because of this, many oncology programs, including the Commission of Cancer, benchmark navigation primarily through operational metrics such as:

  • Time from abnormal finding to diagnostic resolution
  • Time from diagnosis to treatment initiation
  • Time from referral to first oncology consultation

These intervals are where the literature shows the most consistent improvement.

The SilverSummit and XpediteMD program: Project Accelerate

Recent payer provider programs are reinforcing these findings in real clinical environments.

A breast cancer navigation initiative between XpediteMD and SilverSummit Healthplan demonstrated measurable reductions in time to treatment after navigation workflows were implemented.

According to the program announcement, the navigation model focuses on:

  • Rapid outreach after abnormal screening results
  • Coordinating imaging, biopsy, and specialist visits
  • Removing administrative barriers such as scheduling delays and prior authorization issues

Early results reported by the program show meaningful improvements in time to treatment initiation for breast cancer patients, an indicator closely associated with better clinical outcomes and lower overall cost of care.


Programs like this are important because they move navigation evidence beyond research settings into payer-supported population programs.

More here: https://www.lasvegasheals.org/new-silversummit-program-accelerates-breast-cancer-care/

Navigation improves patient experience and barrier resolution

Beyond timeliness, navigation programs help patients overcome logistical and social barriers that often delay care.

A systematic review of cancer navigation studies found that:

  • 70 percent of studies showed improvement in treatment initiation
  • 71 percent showed improved treatment adherence
  • 87 percent reported improved patient satisfaction

Another study evaluating oncology nurse navigator involvement found higher patient satisfaction scores across multiple care experience metrics when navigators were involved.

These improvements often come from navigators addressing barriers such as:

  • Insurance and authorization delays
  • Transportation challenges
  • Appointment coordination across multiple specialists
  • Patient education and emotional support

Making navigation sustainable through reimbursement

Historically, one of the biggest challenges for navigation programs was financial sustainability. Many practices recognized the clinical value of navigation but struggled to justify the staffing costs without clear reimbursement pathways.

Recent CMS billing pathways have started to change that. With codes such as Principal Illness Navigation (PIN) and Principal Care Management (PCM), many navigation activities can now be documented and billed when performed by clinical staff under physician supervision.


When navigation becomes a billable service, practices can shift from viewing it as an unfunded support role to treating it as a structured component of care delivery. This allows programs to:

  • Fund dedicated navigation staff
  • Standardize workflows and documentation
  • Track measurable outcomes tied to reimbursement
  • Scale navigation across more patients

In practice, this financial alignment helps ensure that navigation is not dependent on grants or temporary initiatives but becomes embedded in routine oncology operations.

How oncology programs should benchmark navigation

Because navigation models vary across institutions and tumor types, there is no single universal benchmark. Most mature programs track a balanced set of operational and patient outcomes.

Common navigation benchmarks include:

  • Time to diagnostic resolution
  • Time to treatment initiation
  • Barrier identification and resolution rates
  • Treatment adherence and completion
  • Patient experience measures
  • Avoidable emergency department utilization

Programs that introduce navigation early in the diagnostic pathway, such as the SilverSummit initiative, often show the strongest impact because delays are addressed before they compound.

The bottom line

The evidence increasingly supports oncology navigation as a driver of both clinical performance and operational efficiency. Research consistently shows faster diagnosis and treatment initiation, while real world programs like the partnership between XpediteMD and SilverSummit demonstrate how navigation can scale across payer populations.

As reimbursement pathways expand, navigation is also becoming financially sustainable. This shift allows oncology practices to treat navigation not just as a patient support service but as a core operational function that improves outcomes, patient experience, and care coordination across the cancer journey.

References

  1. Freund KM et al. Impact of Patient Navigation on Timely Cancer Care: The Patient Navigation Research Program. https://pmc.ncbi.nlm.nih.gov/articles/PMC4072900/
  1. Chen M et al. Patient Navigation in Cancer Treatment: A Systematic Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC11063100/
  1. Las Vegas HEALS. New SilverSummit Program Accelerates Breast Cancer Care with XpediteMD. https://www.lasvegasheals.org/new-silversummit-program-accelerates-breast-cancer-care

  2. Yackzan S et al. Patient Satisfaction Scores and Contact With Oncology Nurse Navigators. https://pubmed.ncbi.nlm.nih.gov/30682008/

Latest from our Content Team

Our team brings valuable content for your clinical team from subject-matter experts

Blog Thumbnail

Cancer Patient Navigation Should Be a Premium Concierge Service

Cancer patient navigation should be a premium concierge service because patients need proactive, personalized coordination that removes friction and accelerates care when it matters most.

Blog Thumbnail

XpediteMD Heads to Two Major Oncology Conferences in Q1 2026

XpediteMD will be at ACRO and NCBC in Q1 2026, showcasing how billable, low burden cancer navigation improves Time to Treatment and unlocks sustainable revenue for oncology practices.

Request a Demo Today

And see the XpediteMD Cancer Patient Navigation
Platform in Action

CTA ShapeCTA Shape
Estimate Navigation Revenue

See how much revenue / wRVU you can make a year from navigation activities with our simple Navigation Revenue Calculator.

Estimate My Revenue